Impending corneal perforation after collagen cross-linking for herpetic keratitis

J Cataract Refract Surg. 2013 Apr;39(4):638-41. doi: 10.1016/j.jcrs.2013.02.006.

Abstract

Collagen crosslinking (CXL) has been proposed as a treatment for infectious keratitis. Given the insurgence of antibiotic-resistant microorganisms and frequent toxicity of topical medications, CXL may be a potential treatment for corneal infections. However, corneal infection is itself a possible complication of this treatment. We describe a case of severe corneal thinning and melting in a woman who had a CXL procedure as a treatment for herpetic keratitis.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acyclovir / therapeutic use
  • Antiviral Agents / therapeutic use*
  • Collagen / metabolism*
  • Combined Modality Therapy
  • Cornea / pathology
  • Corneal Perforation / etiology*
  • Corneal Perforation / pathology
  • Corneal Perforation / surgery
  • Corneal Stroma / metabolism
  • Cross-Linking Reagents / therapeutic use*
  • Female
  • Humans
  • Keratitis, Herpetic / drug therapy
  • Keratitis, Herpetic / surgery
  • Keratitis, Herpetic / therapy*
  • Keratoplasty, Penetrating
  • Middle Aged
  • Photochemotherapy*
  • Photosensitizing Agents / therapeutic use
  • Postoperative Complications*
  • Riboflavin / therapeutic use
  • Ultraviolet Rays

Substances

  • Antiviral Agents
  • Cross-Linking Reagents
  • Photosensitizing Agents
  • Collagen
  • Riboflavin
  • Acyclovir